Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan-Reference-Cited by-同舟云学术

Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan

Published:2012-10-04 Issue:7 Volume:53 Page:1393-1404
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Taira Rikizo,Satake Masahiro,Momose Shun'ya,Hino Satoru,Suzuki Yoshiharu,Murokawa Hiroyuki,Uchida Shigeharu,Tadokoro Kenji

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2012.03909.x/fullpdf

Reference36 articles.

1. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale;Tanaka;Intervirology,2011

2. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000;Tanaka;Intervirology,2004

3. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV;Ohnuma;Microbiol Immunol,2001

4. Occult hepatitis B virus infection: implications in transfusion;Allain;Vox Sang,2004

5. Statements from the Taormina expert meeting on occult hepatitis B virus infection;Raimondo;J Hepatol,2008

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood donation screening for hepatitis B virus core antibodies: The importance of confirmatory testing and initial implication for rare blood donor groups;Vox Sanguinis;2024-02-28

2. Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low resource setting;Heliyon;2024-02

3. Molecular testing in hepatitis virus-related disease;Diagnostic Molecular Pathology;2024

4. Marked reduction in the incidence of transfusion‐transmitted hepatitis B virus infection after the introduction of antibody to hepatitis B core antigen and individual donation nucleic acid amplification screening in Japan;Transfusion;2023-09-28

5. Evaluating the cost-effectiveness of low-level HBV DNA screening in occult hepatitis B infection donors: A study from Shandong Blood Center, China;Heliyon;2023-08